Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool

Validation of a Pediatric Abstinence Syndrome Scoring Tool Utilizing a Standardized Hospital-Based Guideline for Iatrogenic Opioid Dependence

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00792415

Enrollment

Registered

2008-11-18

Start date

2009-11-30

Completion date

2010-12-31

Last updated

2025-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Withdrawal Syndrome

Keywords

Abstinence syndrome symptoms, Withdrawal symptoms, Opioid dependence

Brief summary

The purpose of this study is to assess the validity and reliability of an abstinence syndrome assessment tool used in pediatric patients with iatrogenic opioid dependence.

Detailed description

None available.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

2 Weeks to 18 Years

Healthy volunteers

Inclusion criteria

* Pediatric Intensive Care Unit patients ages 2 weeks to 18 years * Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more

Exclusion criteria

* Attending discretion * Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation

Design outcomes

Primary

Measure	Time frame	Description
Total scores of abstinence syndrome symptoms	Up to 23 days	None available - PI no longer with Banner

Secondary

Measure	Time frame	Description
Expert opinion on abstinence syndrome	Up to 23 days	None available - PI no longer with Banner

Countries

United States

Outcome results